Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668532 | SCV000793151 | pathogenic | Xeroderma pigmentosum, group C | 2017-08-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001532475 | SCV001748054 | pathogenic | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001532475 | SCV002231025 | pathogenic | not provided | 2023-09-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553148). This sequence change creates a premature translational stop signal (p.Ala116Tyrfs*4) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (no rsID available, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 23173980). |
Baylor Genetics | RCV000668532 | SCV005055912 | pathogenic | Xeroderma pigmentosum, group C | 2023-12-26 | criteria provided, single submitter | clinical testing |